Client News

Medigene AG: Medigene presents poster on in vitro evaluation of TCR efficacy and toxicity at AACR

MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis

InflaRx Receives Approval to Initiate Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum

NOXXON files application for Phase ½ clinical trial combining NOX-A12 & radiotherapy for the treatment of brain cancer patients

Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers

Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update

Medigene AG: Medigene presents development strategies for TCR therapies at CAR-TCR Summit Europe

Medigene AG: European Patent covering TCR library suitable for the development of neoantigen-specific TCRs

Medigene AG: Medigene participates at upcoming conferences

MorphoSys AG: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire